VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer

NCT02371447 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
39
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Swiss Cancer Institute